A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicityMarta Compte, Luis Álvarez‐Vallina|Nature Communications|2018Cited by 143
ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapySeandean L. Harwood, Luis Álvarez‐Vallina|OncoImmunology|2017Cited by 81